Akari Therapeutics (AKTX) Depreciation & Amortization (CF) (2014 - 2024)

Akari Therapeutics (AKTX) posted quarterly Depreciation & Amortization (CF) of $1000.0 for Q4 2024, little changed year-on-year from $1000.0 in Q1 2024, and down 92.31% on a QoQ basis from $13000.0 in Q1 2024.

Akari Therapeutics (AKTX) Depreciation & Amortization (CF) (2014 - 2024) Analysis & Trends

Akari Therapeutics (AKTX) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $1000.0 the latest figure, recorded in Q4 2024.

  • Quarterly Depreciation & Amortization (CF) changed 0.0% year-over-year to $1000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $1000.0 (down 92.86% YoY) and the FY2024 annual result came in at $14000.0, up 250.0% from the prior year.
  • Depreciation & Amortization (CF) fell to $1000.0 in Q4 2024 per AKTX's latest filing, from $13000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for AKTX reached as high as $13000.0 in Q1 2024 and fell as low as $986.0 in Q3 2020.
  • A 3-year average of $2690.7 and a median of $1000.0 in 2020 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2020 — Depreciation & Amortization (CF) plunged 78.69% — and 2024, when it jumped 1200.0%.
  • Year by year, Depreciation & Amortization (CF) stood at $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $1000.0, $13000.0, and $1000.0 for Q4 2024, Q1 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Akari Therapeutics 86.55 Mn 86.55 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 1,000.00
Dec 31, 2024 1,000.00
Mar 31, 2024 13,000.00
Mar 31, 2024 13,000.00
Dec 31, 2023 1,000.00
Dec 31, 2023 1,000.00
Sep 30, 2023 1,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 1,000.00
Jun 30, 2023 1,000.00
Mar 31, 2023 1,000.00
Mar 31, 2023 1,000.00
Dec 31, 2020 1,000.00
Dec 31, 2020 1,000.00
Sep 30, 2020 986.00
Sep 30, 2020 986.00
Jun 30, 2020 3,044.00
Jun 30, 2020 3,044.00
Mar 31, 2020 3,877.00
Mar 31, 2020 3,877.00